|4Jan 5, 7:43 PM ET

McGroarty Jeffrey Brian 4

4 · Annovis Bio, Inc. · Filed Jan 5, 2022

Insider Transaction Report

Form 4
Period: 2022-01-03
McGroarty Jeffrey B
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-03+28,00028,000 total
    Exercise: $19.78Exp: 2032-01-03Common Stock (28,000 underlying)
Footnotes (1)
  • [F1]The stock option shall vest in eight consecutive quarterly installments of 3,500 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024.

Documents

1 file
  • 4
    tm221949-5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT